Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: The BRAIN App (Phase 2 SBIR) [NA]

View source ↗

Summary

A Phase 2 SBIR trial evaluating The BRAIN App for dementia, including Alzheimer's disease and vascular dementia, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hopeful Aging | Conditions: Dementia, Alzheimer Disease | NA | Status: RECRUITING